Immune-Related Adverse Events After Cancer Immunotherapy and Safety of Treatment Rechallenge
Immune-Related Adverse Events After Cancer Immunotherapy and Safety of Treatment Rechallenge
Recruiting · NCT07453342 · Registry updated 2026-03-06Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Immune-Related Adverse Events After Cancer Immunotherapy and Safety of Treatment Rechallenge | Immune-Related Adverse Events | Recruiting | Not stated | 2026-03-06 | NCT07453342 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Peking Union Medical College Hospital | 417 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Peking Union Medical College Hospital, Chinese Academy of Medical Sciences | Beijing | China | 11 |